What stocks does Nippon India Pharma Fund hold?

Nippon India Pharma Fund holds a portfolio of Indian equity stocks disclosed monthly by Nippon India Mutual Fund to AMFI. The complete current holdings with weights and month-over-month changes are available on this page. Data is sourced from official AMFI portfolio disclosures.

Which AMC manages Nippon India Pharma Fund?

Nippon India Pharma Fund is managed by Nippon India Mutual Fund, a SEBI-registered Asset Management Company in India.

What category is Nippon India Pharma Fund?

Nippon India Pharma Fund is classified as a Equity mutual fund under SEBI's mutual fund categorisation framework.

How often is Nippon India Pharma Fund portfolio data updated?

Portfolio holdings for Nippon India Pharma Fund are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

← Nippon India Mutual Fund

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

Equity Data as of May 2026 Comparing Apr 2026 → May 2026

Share: WhatsApp X

Stocks Held

May 2026

Equity Holdings

₹8,456.05 Cr

Equity only, excl. debt & cash

Top 5 Weight

39.3%

Moderate

Top 10 Weight

58.8%

Moderate

Changes

0 new · 0 exits

Top Sector

Pharmaceuticals & Biotechnology

72.4% of portfolio

📋 What Happened This Month Among existing holdings, Mankind Pharma Limited saw the biggest increase — now at 3.94% of the portfolio. Divi's Laboratories Limited was trimmed the most, now at 5.80%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 72.4%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

How Has the NAV Performed?

1 year history · Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

+2.28%

+11.58%

+8.85%

+8.94%

Latest NAV

₹619.81

24 Jun 2026

52W High

₹619.81

At High

52W Low

₹501.48

+24% from Low

Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025

-2.5%

2024

+35.3%

2023

+40.4%

2022

-9.1%

2021

+25.1%

2020

+67.9%

2019

+2.5%

2018

+4.6%

2017

+8.6%

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

18.6%

+ve in 74% windows

88.4% / -14.9%

3Y Rolling Avg

19.2% p.a.

+ve in 99% windows

33.5% / -1.6%

5Y Rolling Avg

20.4% p.a.

+ve in 100% windows

32.2% / 12.3%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

-14.7%

Rec: Jul 2025 (7 mo)

COVID-19 Crash

-21.2%

Rec: Apr 2020 (1 mo)

2022 Rate Hike

-16.1%

Rec: Jun 2023 (1yr 5mo)

2018 IL&FS

-11.3%

Rec: Feb 2020 (1yr 11mo)

Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. What do these mean? →

Sharpe Ratio (3Y)

1.44

Return per unit of risk. >1 is good.

Sortino Ratio (3Y)

2.15

Penalises downside volatility only.

Std Deviation (3Y)

13.0%

Lower = more consistent returns.

NAV Chart ₹619.81 24 Jun 2026

Simple Moving Avg: Click to draw · click again to remove

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

Chart shows indexed performance (base = 100). Actual NAV: ₹619.81

Sector Shift Industry allocation month-over-month

Mar 2026 → Apr 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	75.3%	73.6%	▼ -1.7%
Healthcare Services	20.3%	21.3%	▲ +1.0%
Retailing	3.9%	3.8%	● -0.1%

Apr 2026 → May 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	73.6%	72.4%	▼ -1.2%
Healthcare Services	21.3%	21.9%	▲ +0.6%
Retailing	3.8%	3.7%	▼ -0.1%

↑

Biggest Add

Mankind Pharma Limited

+0.90% · now 3.94%

↓

Biggest Trim

Divi's Laboratories Limited

-0.81% · now 5.80%

What Changed in the Portfolio This Month?

Comparing Apr 2026 → May 2026

Apr 2026 → May 2026

↑ 12 Increased ↓ 22 Decreased

#	Stock	Sector	Apr 2026	May 2026	Change
1	Mankind Pharma Limited ₹339.99 Cr	Pharmaceuticals & Biotechnology	3.04%	3.94%	+0.90%
2	Cipla Limited ₹531.69 Cr	Pharmaceuticals & Biotechnology	5.47%	6.16%	+0.69%
3	Thyrocare Technologies Limited ₹221.10 Cr	Healthcare Services	2.11%	2.56%	+0.45%
4	Gland Pharma Limited ₹180.12 Cr	Pharmaceuticals & Biotechnology	1.68%	2.09%	+0.41%
5	Syngene International Limited ₹154.77 Cr	Healthcare Services	1.43%	1.79%	+0.36%
6	Apollo Hospitals Enterprise Limited ₹448.72 Cr	Healthcare Services	5.01%	5.20%	+0.19%
7	Sai Life Sciences Limited ₹296.47 Cr	Pharmaceuticals & Biotechnology	3.27%	3.43%	+0.16%
8	Biocon Limited ₹62.98 Cr	Pharmaceuticals & Biotechnology	0.63%	0.73%	+0.10%
9	Narayana Hrudayalaya Limited ₹156.05 Cr	Healthcare Services	1.74%	1.81%	+0.07%
10	Abbott India Limited ₹199.64 Cr	Pharmaceuticals & Biotechnology	2.26%	2.31%	+0.05%
11	Ajanta Pharma Limited ₹277.17 Cr	Pharmaceuticals & Biotechnology	3.19%	3.21%	+0.02%
12	AstraZeneca Pharma India Limited ₹54.01 Cr	Pharmaceuticals & Biotechnology	0.61%	0.63%	+0.02%

#	Stock	Sector	Apr 2026	May 2026	Change
1	Divi's Laboratories Limited ₹500.53 Cr	Pharmaceuticals & Biotechnology	6.61%	5.80%	-0.81%
2	Lupin Limited ₹631.33 Cr	Pharmaceuticals & Biotechnology	7.95%	7.31%	-0.64%
3	Aurobindo Pharma Limited ₹200.07 Cr	Pharmaceuticals & Biotechnology	2.83%	2.32%	-0.51%
4	Sun Pharmaceutical Industries Limited ₹1,152.63 Cr	Pharmaceuticals & Biotechnology	13.85%	13.35%	-0.50%
5	Dr. Reddy's Laboratories Limited ₹580.02 Cr	Pharmaceuticals & Biotechnology	7.04%	6.72%	-0.32%
6	GlaxoSmithKline Pharmaceuticals Limited ₹201.84 Cr	Pharmaceuticals & Biotechnology	2.55%	2.34%	-0.21%
7	Max Healthcare Institute Limited ₹256.53 Cr	Healthcare Services	3.16%	2.97%	-0.19%
8	Vijaya Diagnostic Centre Limited ₹277.09 Cr	Healthcare Services	3.36%	3.21%	-0.15%
9	Sanofi India Limited ₹71.32 Cr	Pharmaceuticals & Biotechnology	0.94%	0.83%	-0.11%
10	MedPlus Health Services Limited ₹317.37 Cr	Retailing	3.78%	3.68%	-0.10%
11	Pfizer Limited ₹146.35 Cr	Pharmaceuticals & Biotechnology	1.79%	1.69%	-0.10%
12	IPCA Laboratories Limited ₹208.04 Cr	Pharmaceuticals & Biotechnology	2.50%	2.41%	-0.09%
13	Dr. Lal Path Labs Limited ₹163.67 Cr	Healthcare Services	1.99%	1.90%	-0.09%
14	SANOFI CONSUMER HEALTHCARE ₹98.04 Cr	Pharmaceuticals & Biotechnology	1.22%	1.14%	-0.08%
15	Akums Drugs and Pharmaceuticals Limited ₹79.48 Cr	Pharmaceuticals & Biotechnology	0.99%	0.92%	-0.07%
16	Alkem Laboratories Limited ₹177.96 Cr	Pharmaceuticals & Biotechnology	2.09%	2.06%	-0.03%
17	Emcure Pharmaceuticals Limited ₹126.58 Cr	Pharmaceuticals & Biotechnology	1.50%	1.47%	-0.03%
18	Suraksha Diagnostic Ltd ₹111.36 Cr	Healthcare Services	1.32%	1.29%	-0.03%
19	Fortis Healthcare Limited ₹102.49 Cr	Healthcare Services	1.22%	1.19%	-0.03%
20	Anthem Biosciences Limited ₹80.44 Cr	Pharmaceuticals & Biotechnology	0.96%	0.93%	-0.03%
21	Indoco Remedies Ltd ₹38.47 Cr	Pharmaceuticals & Biotechnology	0.46%	0.45%	-0.01%
22	Concord Biotech Limited ₹11.75 Cr	Pharmaceuticals & Biotechnology	0.15%	0.14%	-0.01%

What Stocks Does This Fund Hold?

34 stocks — May 2026

#	Stock	Sector	Weight & Value
1	Sun Pharmaceutical Industries Limited ₹1,152.63 Cr	Pharmaceuticals & Biotechnology	13.35%
2	Lupin Limited ₹631.33 Cr	Pharmaceuticals & Biotechnology	7.31%
3	Dr. Reddy's Laboratories Limited ₹580.02 Cr	Pharmaceuticals & Biotechnology	6.72%
4	Cipla Limited ₹531.69 Cr	Pharmaceuticals & Biotechnology	6.16%
5	Divi's Laboratories Limited ₹500.53 Cr	Pharmaceuticals & Biotechnology	5.80%
6	Apollo Hospitals Enterprise Limited ₹448.72 Cr	Healthcare Services	5.20%
7	Mankind Pharma Limited ₹339.99 Cr	Pharmaceuticals & Biotechnology	3.94%
8	MedPlus Health Services Limited ₹317.37 Cr	Retailing	3.68%
9	Sai Life Sciences Limited ₹296.47 Cr	Pharmaceuticals & Biotechnology	3.43%
10	Vijaya Diagnostic Centre Limited ₹277.09 Cr	Healthcare Services	3.21%
11	Ajanta Pharma Limited ₹277.17 Cr	Pharmaceuticals & Biotechnology	3.21%
12	Max Healthcare Institute Limited ₹256.53 Cr	Healthcare Services	2.97%
13	Thyrocare Technologies Limited ₹221.10 Cr	Healthcare Services	2.56%
14	IPCA Laboratories Limited ₹208.04 Cr	Pharmaceuticals & Biotechnology	2.41%
15	GlaxoSmithKline Pharmaceuticals Limited ₹201.84 Cr	Pharmaceuticals & Biotechnology	2.34%
16	Aurobindo Pharma Limited ₹200.07 Cr	Pharmaceuticals & Biotechnology	2.32%
17	Abbott India Limited ₹199.64 Cr	Pharmaceuticals & Biotechnology	2.31%
18	Gland Pharma Limited ₹180.12 Cr	Pharmaceuticals & Biotechnology	2.09%
19	Alkem Laboratories Limited ₹177.96 Cr	Pharmaceuticals & Biotechnology	2.06%
20	Dr. Lal Path Labs Limited ₹163.67 Cr	Healthcare Services	1.90%
21	Narayana Hrudayalaya Limited ₹156.05 Cr	Healthcare Services	1.81%
22	Syngene International Limited ₹154.77 Cr	Healthcare Services	1.79%
23	Pfizer Limited ₹146.35 Cr	Pharmaceuticals & Biotechnology	1.69%
24	Emcure Pharmaceuticals Limited ₹126.58 Cr	Pharmaceuticals & Biotechnology	1.47%
25	Suraksha Diagnostic Ltd ₹111.36 Cr	Healthcare Services	1.29%
26	Fortis Healthcare Limited ₹102.49 Cr	Healthcare Services	1.19%
27	SANOFI CONSUMER HEALTHCARE ₹98.04 Cr	Pharmaceuticals & Biotechnology	1.14%
28	Anthem Biosciences Limited ₹80.44 Cr	Pharmaceuticals & Biotechnology	0.93%
29	Akums Drugs and Pharmaceuticals Limited ₹79.48 Cr	Pharmaceuticals & Biotechnology	0.92%
30	Sanofi India Limited ₹71.32 Cr	Pharmaceuticals & Biotechnology	0.83%
31	Biocon Limited ₹62.98 Cr	Pharmaceuticals & Biotechnology	0.73%
32	AstraZeneca Pharma India Limited ₹54.01 Cr	Pharmaceuticals & Biotechnology	0.63%
33	Indoco Remedies Ltd ₹38.47 Cr	Pharmaceuticals & Biotechnology	0.45%
34	Concord Biotech Limited ₹11.75 Cr	Pharmaceuticals & Biotechnology	0.14%